Saturday, September 20, 2014 7:29:11 PM
Now, does this stock move solely on retail, or is LPC running the show? That is what I would like to know.
If you fail on Lympro, push back Eltoprazine, note that the pps will not be high enough for an uplist and then double the A/S in the setting of JUST having used up a BIllION Shares, with the need to use at least HALF those remaining shares in the next two years, then the pps is going to go down.
If they make an announcement that changes the fundamentals then the pps will go up.
Furthermore, you can generally tell by the posts is the pps is going up or down. There is an ebb and flow to the post type. More on that later.
The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is.
Winston Churchill
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM